de Citigroup Universal Health Services UHS Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 18 M | Comprar |
121,209
+62,504
| +106% | +USD 10.2 M | 0.01% | 1221 |
|
|
2026
Q1 | USD 10.5 M | Comprar |
58,705
+6,473
| +12% | +USD 1.33 M | ﹤0.01% | 1445 |
|
|
2025
Q4 | USD 11.4 M | Comprar |
52,232
+7,457
| +17% | +USD 1.65 M | 0.01% | 1438 |
|
|
2025
Q3 | USD 9.15 M | Vender |
44,775
-5,346
| -11% | -USD 962 k | ﹤0.01% | 1554 |
|
|
2025
Q2 | USD 9.08 M | Vender |
50,121
-24,947
| -33% | -USD 4.5 M | ﹤0.01% | 1442 |
|
|
2025
Q1 | USD 14.1 M | Comprar |
75,068
+21,058
| +39% | +USD 3.84 M | 0.01% | 1154 |
|
|
2024
Q4 | USD 9.7 M | Vender |
54,010
-23,597
| -30% | -USD 4.81 M | 0.01% | 1392 |
|
|
2024
Q3 | USD 17.8 M | Comprar |
77,607
+27,498
| +55% | +USD 5.93 M | 0.01% | 1007 |
|
|
2024
Q2 | USD 9.27 M | Comprar |
50,109
+22,884
| +84% | +USD 4.05 M | 0.01% | 1292 |
|
|
2024
Q1 | USD 4.97 M | Vender |
27,225
-168
| -0.6% | -USD 27.7 k | ﹤0.01% | 1705 |
|
|
2023
Q4 | USD 4.18 M | Comprar |
27,393
+5,889
| +27% | +USD 793 k | ﹤0.01% | 1706 |
|
|
2023
Q3 | USD 2.7 M | Vender |
21,504
-16,370
| -43% | -USD 2.23 M | ﹤0.01% | 1796 |
|
|
2023
Q2 | USD 5.98 M | Vender |
37,874
-370
| -1% | -USD 51.6 k | ﹤0.01% | 1387 |
|
|
2023
Q1 | USD 4.86 M | Comprar |
38,244
+12,330
| +48% | +USD 1.7 M | ﹤0.01% | 1518 |
|
|
2022
Q4 | USD 3.65 M | Vender |
25,914
-55,066
| -68% | -USD 6.5 M | ﹤0.01% | 1651 |
|
|
2022
Q3 | USD 7.14 M | Comprar |
80,980
+48,611
| +150% | +USD 5.02 M | 0.01% | 1337 |
|
|
2022
Q2 | USD 3.26 M | Vender |
32,369
-17,990
| -36% | -USD 2.25 M | ﹤0.01% | 1775 |
|
|
2022
Q1 | USD 7.3 M | Comprar |
50,359
+14,648
| +41% | +USD 2.03 M | ﹤0.01% | 1463 |
|
|
2021
Q4 | USD 4.63 M | Comprar |
35,711
+1,316
| +4% | +USD 169 k | ﹤0.01% | 1894 |
|
|
2021
Q3 | USD 4.76 M | Vender |
34,395
-12,211
| -26% | -USD 1.85 M | ﹤0.01% | 1856 |
|
|
2021
Q2 | USD 6.82 M | Vender |
46,606
-42,224
| -48% | -USD 6.38 M | ﹤0.01% | 1673 |
|
|
2021
Q1 | USD 11.8 M | Comprar |
88,830
+23,424
| +36% | +USD 3.11 M | 0.01% | 1270 |
|
|
2020
Q4 | USD 8.99 M | Comprar |
65,406
+5,214
| +9% | +USD 649 k | 0.01% | 1655 |
|
|
2020
Q3 | USD 6.44 M | Comprar |
60,192
+15,202
| +34% | +USD 1.63 M | ﹤0.01% | 1715 |
|
|
2020
Q2 | USD 4.18 M | Vender |
44,990
-12,746
| -22% | -USD 1.27 M | ﹤0.01% | 2034 |
|
|
2020
Q1 | USD 5.72 M | Comprar |
57,736
+4,478
| +8% | +USD 567 k | 0.01% | 1551 |
|
|
2019
Q4 | USD 7.64 M | Comprar |
53,258
+3,766
| +8% | +USD 537 k | 0.01% | 1693 |
|
|
2019
Q3 | USD 7.36 M | Vender |
49,492
-64,706
| -57% | -USD 9.29 M | 0.01% | 1620 |
|
|
2019
Q2 | USD 14.9 M | Comprar |
114,198
+55,537
| +95% | +USD 6.99 M | 0.01% | 1114 |
|
|
2019
Q1 | USD 7.85 M | Comprar |
58,661
+22,607
| +63% | +USD 2.98 M | 0.01% | 1439 |
|
|
2018
Q4 | USD 4.2 M | Vender |
36,054
-7,193
| -17% | -USD 904 k | ﹤0.01% | 1971 |
|
|
2018
Q3 | USD 5.53 M | Comprar |
43,247
+30,739
| +246% | +USD 3.77 M | ﹤0.01% | 1767 |
|
|
2018
Q2 | USD 1.39 M | Vender |
12,508
-35,562
| -74% | -USD 4.17 M | ﹤0.01% | 3033 |
|
|
2018
Q1 | USD 5.69 M | Comprar |
48,070
+23,931
| +99% | +USD 2.84 M | ﹤0.01% | 1655 |
|
|
2017
Q4 | USD 2.74 M | Vender |
24,139
-12,113
| -33% | -USD 1.29 M | ﹤0.01% | 2380 |
|
|
2017
Q3 | USD 4.02 M | Comprar |
36,252
+10,196
| +39% | +USD 1.15 M | ﹤0.01% | 1963 |
|
|
2017
Q2 | USD 3.18 M | Vender |
26,056
-7,449
| -22% | -USD 887 k | ﹤0.01% | 2103 |
|
|
2017
Q1 | USD 4.17 M | Comprar |
33,505
+31,334
| +1,443% | +USD 3.7 M | ﹤0.01% | 1802 |
|
|
2016
Q4 | USD 230 k | Vender |
2,171
-896
| -29% | -USD 106 k | ﹤0.01% | 5163 |
|
|
2016
Q3 | USD 378 k | Comprar |
3,067
+444
| +17% | +USD 56.2 k | ﹤0.01% | 4148 |
|
|
2016
Q2 | USD 352 k | Vender |
2,623
-1,296
| -33% | -USD 171 k | ﹤0.01% | 3996 |
|
|
2016
Q1 | USD 490 k | Comprar |
3,919
+1,309
| +50% | +USD 147 k | ﹤0.01% | 4130 |
|
|
2015
Q4 | USD 312 k | Vender |
2,610
-301
| -10% | -USD 36.8 k | ﹤0.01% | 4325 |
|
|
2015
Q3 | USD 364 k | Vender |
2,911
-10,909
| -79% | -USD 1.52 M | ﹤0.01% | 4041 |
|
|
2015
Q2 | USD 1.96 M | Comprar |
13,820
+3,426
| +33% | +USD 429 k | ﹤0.01% | 2536 |
|
|
2015
Q1 | USD 1.22 M | Comprar |
10,394
+1,864
| +22% | +USD 206 k | ﹤0.01% | 2925 |
|
|
2014
Q4 | USD 949 k | Comprar |
8,530
+5,306
| +165% | +USD 557 k | ﹤0.01% | 3191 |
|
|
2014
Q3 | USD 338 k | Vender |
3,224
-17,780
| -85% | -USD 1.89 M | ﹤0.01% | 3838 |
|
|
2014
Q2 | USD 2.01 M | Vender |
21,004
-145,795
| -87% | -USD 12.6 M | ﹤0.01% | 2473 |
|
|
2014
Q1 | USD 13.7 M | Vender |
166,799
-53,121
| -24% | -USD 4.28 M | 0.01% | 955 |
|
|
2013
Q4 | USD 17.9 M | Comprar |
219,920
+216,411
| +6,167% | +USD 17.3 M | 0.02% | 835 |
|
|
2013
Q3 | USD 264 k | Vender |
3,509
-2,551
| -42% | -USD 178 k | ﹤0.01% | 3933 |
|
|
2013
Q2 | USD 405 k | Comprar |
+6,060
| Nuevas | +USD 400 k | ﹤0.01% | 3674 |
|
Otros fondos que tienen UHS en su cartera
Posición de Citigroup en UHS: resumen de T2 2026
Citigroup aumentó su participación en Universal Health Services (UHS) en 106% durante T2 2026, al comprar aproximadamente USD 10.2 M y elevar la posición a 121,209 acciones con un valor de USD 18 M. La posición representa 0.01% de la cartera y ocupa el puesto #1221.
Citigroup reportó por primera vez una posición en UHS en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 597 fondos que sigue Wall St. Rank mantienen una posición en UHS.
- Al cierre de T2 2026, Citigroup tenía 121,209 acciones de Universal Health Services con un valor de USD 18 M.
- Citigroup compró 62,504 acciones de Universal Health Services en T2 2026, por un monto estimado de USD 10.2 M.
- Universal Health Services representó 0.01% de la cartera de Citigroup en T2 2026 y fue su posición número 1221.
- Citigroup reportó por primera vez una posición en Universal Health Services en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 597 fondos que sigue Wall St. Rank tenían Universal Health Services en cartera.
Según el Informe 13F de Citigroup correspondiente a T2 2026, presentado el 3 ago 2026.